Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Jackson › NPI 1669410940
Lab

Holzer Medical Center Jackson

Holzer Medical Center Jackson was paid $16.10M by Medicaid between Jan 2018 and Dec 2024, across 154 billing codes. Its largest line is 99283, emergency room visit (moderate) — 17% of everything it billed.

33Billing provider infoHOLZER MEDICAL CENTER JACKSON
JACKSON, OH 45640
33aNPI1669410940assigned 06/02/2006
33bProvider typeClinical Medical Laboratory
28Total paid$16.10M
24GClaims376,666
24DCodes billed154
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Ohio

Rank by total paid#14 of 116
Median peer was paid$313K
This provider vs. median51×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201851,293$1.43M
201945,929$1.30M
202033,077$1.39M
202140,146$1.74M
202249,619$2.21M
202395,739$4.11M
2024incomplete60,863$3.92M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 17% 20,847 19,602 $2.77M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 16% 20,010 18,232 $2.59M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 15% 28,833 24,910 $2.38M
96361 Intravenous infusion, hydration; each additional hour 10% 6,106 5,034 $1.69M
70450 Computed tomography, head or brain; without contrast material 4.3% 2,599 2,317 $698K
74176 Computed tomography, abdomen and pelvis; without contrast material 3.8% 2,154 1,969 $610K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.7% 5,951 5,354 $603K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.1% 1,522 1,308 $498K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.9% 3,997 3,816 $464K
99281 Emergency department visit for the evaluation and management, self-limited or minor 2.2% 3,216 3,120 $359K
0240U 2.1% 2,557 2,365 $335K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 2.0% 2,657 2,417 $328K
142 more codes
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.8% 2,599 $289K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.7% 1,052 $275K
71275 Computed tomographic angiography, chest, with contrast material 1.6% 701 $251K
97597 1.5% 2,589 $247K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.3% 2,222 $202K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.2% 2,070 $200K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1.2% 2,011 $190K
20610 1.0% 1,187 $165K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 650 $157K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 369 $126K
80048 Basic metabolic panel (calcium, ionized) <1% 22,900 $113K
84484 <1% 16,270 $46K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 655 $40K
71250 <1% 699 $33K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 443 $31K
G0378 Hospital observation service, per hour <1% 898 $30K
80053 Comprehensive metabolic panel <1% 5,763 $29K
97161 <1% 253 $24K
80076 <1% 10,338 $24K
96368 <1% 301 $23K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 258 $16K
72125 Computed tomography, cervical spine; without contrast material <1% 526 $14K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 29,820 $14K
71045 Radiologic examination, chest; single view <1% 9,028 $14K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 120 $12K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 14,364 $11K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 685 $10K
96367 <1% 198 $10K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 55 $9K
83605 <1% 5,138 $8K
70486 <1% 99 $8K
84443 Thyroid stimulating hormone (TSH) <1% 1,707 $8K
80320 <1% 360 $7K
97162 <1% 125 $7K
12001 <1% 39 $6K
36415 Collection of venous blood by venipuncture <1% 27,463 $6K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 29 $6K
71046 Radiologic examination, chest; 2 views <1% 1,163 $5K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 60 $5K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 69 $5K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 6,662 $5K
73630 <1% 432 $4K
73562 <1% 381 $4K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 29 $3K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 13 $3K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 8,601 $3K
73610 <1% 349 $3K
11721 <1% 190 $3K
87040 <1% 3,173 $3K
81001 <1% 12,875 $2K
96375 Therapeutic injection; each additional sequential IV push <1% 4,439 $2K
73030 <1% 229 $2K
96376 <1% 944 $2K
97166 <1% 29 $2K
94664 <1% 1,271 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 780 $2K
90715 <1% 105 $2K
73110 <1% 130 $2K
73130 <1% 203 $2K
82962 <1% 2,345 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 200 $2K
85610 <1% 7,144 $1K
99406 <1% 147 $1K
93971 <1% 12 $1K
86140 <1% 2,920 $1K
80061 Lipid panel <1% 93 $1K
83690 <1% 5,359 $1K
93922 <1% 14 $1K
J3490 Unclassified drugs <1% 147 $1K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,727 $1K
85730 <1% 6,942 $1K
83880 <1% 1,733 $966.51
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 2,474 $950.97
81025 <1% 2,151 $700.40
82803 <1% 1,101 $692.22
80306 <1% 636 $589.49
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 640 $552.82
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 42 $550.03
84702 <1% 91 $539.37
82553 <1% 76 $537.18
87420 <1% 18 $528.66
94660 <1% 16 $521.58
83735 <1% 1,641 $492.80
85379 <1% 740 $470.01
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 28 $456.42
90686 <1% 64 $450.26
81003 <1% 1,196 $443.06
86900 <1% 17 $387.61
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,067 $372.33
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,525 $360.00
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,388 $358.01
82150 <1% 809 $343.89
82140 <1% 190 $328.71
73502 <1% 19 $323.61
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 77 $282.24
87186 <1% 812 $198.80
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 243 $194.37
87077 <1% 819 $181.77
85652 <1% 158 $173.36
J7030 Infusion, normal saline solution , 1000 cc <1% 3,263 $171.62
J7050 Infusion, normal saline solution, 250 cc <1% 1,753 $171.32
36600 <1% 201 $169.96
J1170 Injection, hydromorphone, up to 4 mg <1% 593 $164.45
82550 <1% 76 $138.61
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 1,471 $110.70
82375 <1% 375 $108.93
84703 <1% 116 $102.80
84100 <1% 115 $98.27
85018 <1% 333 $94.92
87340 <1% 13 $89.51
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 468 $88.91
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,618 $65.34
80329 <1% 216 $62.48
86709 <1% 13 $61.14
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 697 $43.88
82607 <1% 28 $42.88
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 68 $42.56
84439 <1% 13 $36.82
82746 <1% 27 $30.56
86803 <1% 13 $30.56
86706 <1% 13 $30.56
86704 <1% 13 $30.56
J2060 Injection, lorazepam, 2 mg <1% 277 $28.28
J2550 Injection, promethazine hcl, up to 50 mg <1% 202 $25.68
J7060 5% dextrose/water (500 ml = 1 unit) <1% 511 $24.47
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 55 $23.18
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 49 $19.11
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 342 $13.24
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 112 $10.12
J1171 Injection, hydromorphone, 0.1 mg <1% 36 $6.73
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 223 $4.65
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 324 $2.81
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 202 $0.54
84145 0% 37 $0.00
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 0% 16 $0.00
J3370 Injection, vancomycin hcl, 500 mg 0% 36 $0.00
73590 0% 16 $0.00
A9270 Non-covered item or service 0% 835 $0.00
94760 0% 272 $0.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 0% 132 $0.00
G0008 Administration of influenza virus vaccine 0% 95 $0.00
86901 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCANADY, MICHAEL (CEO)